In a randomized clinical trial, researchers from Huntsman Cancer Institute at the University of Utah (the U) have found that short-course, higher dose vaginal brachytherapy for endometrial cancer had ...
A cervical cancer drug may elevate the risk of developing ocular surface disease, such as conjunctival scarring and infectious keratitis.
Opinion
Hosted on MSN16dOpinion
January is all about cervical cancer
January has been designated the Cervical Cancer Awareness Month. According to the World Health Organization, the intention is to raise awareness of cervical cancer and human papilloma virus (HPV) ...
The American Cancer Society made a dire prediction — nearly 13,400 cases of invasive cervical cancer will ... few months it should be evaluated.” “Discharge is usually foul smelling ...
Cervical cancer is one of the most dangerous cancers affecting women, yet it often develops silently. Many women don’t experience obvious symptoms in the early stages, which makes it even more ...
changes to vaginal discharge or pain in your lower back or between your hip bones. Research from Jo’s Cervical Cancer Trust previously showed that almost half of 18-24 year old women believed vaginal ...
Cervical cancer is usually caused by HPV infection. Exposure to multiple sexual partners, especially without using a condom, increases the risk of HPV. In utero diethylstilbestrol (DES) exposure ...
Screening is one of the best ways to protect yourself against this preventable cancer Cervical cancer is diagnosed in more than 3,000 women every year in the UK, according to Cancer Research UK.
such as cervical cancer," explains Milanova. Women should look out for changes to the consistency, smell and amount of vaginal discharge, including thicker discharge, discharge with an unpleasant ...
Ali Alcock from Corwen, Denbighshire, said the test led to her being diagnosed with cervical cancer at the age of 37 back in 2015. She underwent treatment including a full hysterectomy and has now ...
The research question was framed using the PICOS framework. The population included women with HPV infection or cervical cancer, with interventions focusing on cervicovaginal microbiota composition.